• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
EndoChoice Holdings, Inc., a medical device company, designs and commercializes various products for gastrointestinal (GI) caregivers in the United States and internationally.
Market Cap | 208.733 Million | Shares Outstanding | 26.092 Million | Avg 30-day Volume | 46.269 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -2.36 |
Price to Revenue | 2.761 | Debt to Equity | 0.9324 | EBITDA | -61.909 Million |
Price to Book Value | 4.5442 | Operating Margin | -94.19579999999999 | Enterprise Value | 206.907 Million |
Current Ratio | 3.946 | EPS Growth | 0 | Quick Ratio | 2.894 |
1 Yr BETA | 1.516 | 52-week High/Low | 0.0 / | Profit Margin | -95.6823 |
Operating Cash Flow Growth | -16.2409 | Altman Z-Score | -1.6525 | Free Cash Flow to Firm | 0 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
GILL DAVID N PRESIDENT AND CFO |
|
No longer subject to file | 2016-11-22 | 0 |
|
No longer subject to file | 2016-11-22 | 0 | |
|
No longer subject to file | 2016-11-22 | 0 | |
|
No longer subject to file | 2016-11-22 | 0 | |
|
No longer subject to file | 2016-11-22 | 0 | |
|
No longer subject to file | 2016-11-22 | 0 | |
|
No longer subject to file | 2016-11-22 | 0 | |
GILREATH MARK CHIEF EXECUTIVE OFFICER |
|
No longer subject to file | 2016-11-22 | 0 |
|
No longer subject to file | 2016-11-22 | 0 | |
LADD DOUGLAS CHIEF MARKETING OFFICER |
|
67,698 | 2015-12-31 | 0 |
|
2,290,614 | 2015-11-17 | 0 | |
RUBEY KEVIN CHIEF OPERATING OFFICER |
|
66,442 | 2015-08-14 | 0 |
|
2,667,904 | 2015-08-14 | 0 | |
SEQUOIA CAPITAL U.S. GROWTH FUND V, L.P. SEQUOIA CAPITAL USGF PRINCIPALS FUND V, L.P. |
|
3,972,235 | 2015-06-05 | 0 |
RIVER CITIES CAPITAL FUND IV, L.P. |
|
2,662,279 | 2015-06-05 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|
Holder | Issuer | Net Short Position | Position Date | Origin |
---|